Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard R Rubin

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Diabetes Technology & Therapeutics|January 20, 2010
Effect of technosphere inhaled insulin on quality of life and treatment satisfactionMark Peyrot, Richard R Rubin
Diabetes Care|May 28, 2009
How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preferenceMark Peyrot, Richard R Rubin
The Diabetes Educator|February 27, 2009
Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide useRichard R Rubin, Mark Peyrot
Diabetes Technology & Therapeutics|October 18, 2011
Patient-reported outcomes in adults with type 2 diabetes using mealtime inhaled technosphere insulin and basal insulin versus premixed insulinMark Peyrot, Richard R Rubin
Diabetes Technology & Therapeutics|December 24, 2010
Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetesMark Peyrot, Richard R Rubin
Diabetes/Metabolism Research and Reviews|July 12, 2002
Was Willis right? Thoughts on the interaction of depression and diabetesRichard R Rubin, Mark Peyrot
The Diabetes Educator|February 13, 2008
Access to diabetes self-management educationMark Peyrot, Richard R Rubin
Diabetes Technology & Therapeutics|January 10, 2009
Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump systemMark Peyrot, Richard R Rubin
Diabetes Care|November 28, 2007
Factors affecting use of insulin pens by patients with type 2 diabetesRichard R Rubin, Mark Peyrot
Patient Preference and Adherence|July 28, 2011
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive frameworkMark Peyrot, Richard R Rubin
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Diabetes Technology & Therapeutics|January 20, 2010
Effect of technosphere inhaled insulin on quality of life and treatment satisfactionMark Peyrot, Richard R Rubin
Diabetes Care|May 28, 2009
How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preferenceMark Peyrot, Richard R Rubin
The Diabetes Educator|February 27, 2009
Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide useRichard R Rubin, Mark Peyrot
Diabetes Technology & Therapeutics|October 18, 2011
Patient-reported outcomes in adults with type 2 diabetes using mealtime inhaled technosphere insulin and basal insulin versus premixed insulinMark Peyrot, Richard R Rubin
Diabetes Technology & Therapeutics|December 24, 2010
Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetesMark Peyrot, Richard R Rubin
Diabetes/Metabolism Research and Reviews|July 12, 2002
Was Willis right? Thoughts on the interaction of depression and diabetesRichard R Rubin, Mark Peyrot
The Diabetes Educator|February 13, 2008
Access to diabetes self-management educationMark Peyrot, Richard R Rubin
Diabetes Technology & Therapeutics|January 10, 2009
Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump systemMark Peyrot, Richard R Rubin
Diabetes Care|November 28, 2007
Factors affecting use of insulin pens by patients with type 2 diabetesRichard R Rubin, Mark Peyrot
Patient Preference and Adherence|July 28, 2011
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive frameworkMark Peyrot, Richard R Rubin
Pageof 7